Statistical analysis plan for the family-led rehabilitation after stroke in India (ATTEND) trial: A multicenter randomized controlled trial of a new model of stroke rehabilitation compared to usual care. Issue 2 (February 2017)

• Record Type: Journal Article
• Authors: Billot, Laurent; Lindley, Richard I; Harvey, Lisa A; Maulik, Pallab K; Hackett, Maree L; Murthy, Gudlavalleti VS; Anderson, Craig S; Shamanna, Bindiganavale R; Jan, Stephen; Walker, Marion; Forster, Anne; Langhorne, Peter; Verma, Shweta J; Felix, Cynthia; Alim, Mohammed; Gandhi, Dorcas BC; Pandian, Jeyaraj Durai
• Is Part Of: International journal of stroke. Volume 12:Issue 2(2017)
• Page Start: 208
• Page End: 210
• Publication Date: 2017-02
• Subjects: Rehabilitation -- statistical analysis plan -- cost factors -- India -- clinical trial -- disability -- caregivers -- developing countries; 616.8005
• DOI: 10.1177/1747493016674956
• Languages: English
• ISSNs: 1747-4930

Abstract

Background: In low- and middle-income countries, few patients receive organized rehabilitation after stroke, yet the burden of chronic diseases such as stroke is increasing in these countries. Affordable models of effective rehabilitation could have a major impact. The ATTEND trial is evaluating a family-led caregiver delivered rehabilitation program after stroke. Objective: To publish the detailed statistical analysis plan for the ATTEND trial prior to trial unblinding. Methods: Based upon the published registration and protocol, the blinded steering committee and management team, led by the trial statistician, have developed a statistical analysis plan. The plan has been informed by the chosen outcome measures, the data collection forms and knowledge of key baseline data. Results: The resulting statistical analysis plan is consistent with best practice and will allow open and transparent reporting. Conclusions: Publication of the trial statistical analysis plan reduces potential bias in trial reporting, and clearly outlines pre-specified analyses. Clinical Trial Registrations: India CTRI/2013/04/003557; Australian New Zealand Clinical Trials Registry ACTRN1261000078752; Universal Trial Number U1111-1138-6707.